Sam Chun Dang Pharm. Co., Ltd
000250.KQ
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.7T
Close$
$-28454.09
113.9% downside
Current Fair Value
113.9% downsideOvervalued by 113.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.70 Trillion |
|---|---|
| Enterprise Value | $5.70 Trillion |
| Dividend Yield | $50.00 (0.02%) |
| Earnings per Share | $226.24 |
| Beta | 0.96 |
| Outstanding Shares | 23,407,000 |
Return
| Return on Equity | 5.88% |
|---|---|
| Return on Assets | 3.09% |
| Return on Invested Capital | 4.72% |
Valuation & Multiples
| P/E Ratio | 319.27 |
|---|---|
| PEG | -141.07 |
| Price to Sales | 18.42 |
| Price to Book Ratio | 11.94 |
| Enterprise Value to Revenue | 21.93 |
| Enterprise Value to EBIT | 256.47 |
| Enterprise Value to Net Income | 320 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.21 |
Revenue Sources
No data
Insider Trades
Next Earnings Call
Expected Date
November 12, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$39.90 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Sam Chun Dang Pharm. Co., Ltd
375 employees
CEO: Chun In Seok Sam Chun Dang Pharm Co., Ltd. is a pharmaceutical company that develops and produces a wide variety of medications. Its product range features antibiotics, treatments for cardiovascular and respiratory conditions, drugs for the digestive...